Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reacting to the Crisis: Biotech Venture Capital's Plan B

Dec 01 2008

• By Chris Morrison

Related Content

Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch on in a Big Way

Jun 01 2008

Can Big Pharma Save Biotech Investors?

Nov 01 2008

Private Biotech M&A Review: Has the Market Lost Steam?

Sep 01 2008

NovaCardia & Domain: New-Model Spec Pharma Investing

Sep 01 2007

Venture Philanthropy: The New Venture Capital?

Mar 01 2007

Related Companies

Anchor Therapeutics, Inc.

Aegerion Pharmaceuticals, Inc.

Daiichi Sankyo Co., Ltd.

U3 Pharma AG

Bayer AG

Direvo Biotech AG

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Archemix Corp.

NitroMed, Inc.

Micromet, Inc.

Movetis NV

Johnson & Johnson

Domain Therapeutics S.A.

Prolexys Pharmaceuticals, Inc.

TME Pharma N.V.

Sumitomo Pharma Co., Ltd.

Ambrx Biopharma, Inc.

Merck & Co., Inc.

Sequel Pharmaceuticals, Inc.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc.

ARCA Biopharma, Inc.

Nuvelo

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window